Advertisement

Evaluation of the French medical practices in endometrial cancer management by using quality indicators

  • E. Larouzée
    Correspondence
    Corresponding author at: Department of Gynecologic Oncology and Obstetrics, Bichat University Hospital, APHP, Paris, France.
    Affiliations
    Department of Gynecologic Oncology and Obstetrics, Bichat University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine Paris VII, France
    Search for articles by this author
  • J. Phelippeau
    Affiliations
    Department of Gynecologic Oncology and Obstetrics, Bichat University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine Paris VII, France
    Search for articles by this author
  • E. Roberti
    Affiliations
    Department of Radiotherapy, Bichat University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine Paris VII, France
    Search for articles by this author
  • M. Koskas
    Affiliations
    Department of Gynecologic Oncology and Obstetrics, Bichat University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine Paris VII, France
    Search for articles by this author

      Abstract

      Study objective

      To evaluate the French quality of care of endometrial cancer using published relevant quality indicators and researche explanatory factors influencing its management.

      Study design

      We used databases from the “Echantillon Généraliste de Bénéficiaires”, sample of the French population, to identify cases operated on between 2005–2014. Quality indicators evaluated were: three years survival rate, time between surgery and adjuvant treatment, use of IRMT and 3DCRT for radiotherapy, rate of minimally invasive surgery. Multilevel analysis was performed to identify explanatory factors.

      Results

      405 women were included. 323 had a follow-up of more three years, and 250 were alive at three years (77.0%). 70 (17.3%) underwent minimally invasive surgery. 73 women of the 153 who received adjuvant treatment (47.8%) started it within 60 days after surgery. Among the 60 patients who received adjuvant radiotherapy, 50 (83.3%) underwent the IRMT or 3DCRT technique. In multilevel analysis, diabetes (OR = 1.24: 95% CI [1.08; 1.41]), and age under 65 (OR = 1.15: 95% CI [1.01; 1.35]) were associated with an increase of the three years survival rate.
      Lymphadenectomy (OR = 1.12: 95% CI [1.03; 1.22]), and management in an university institution (OR = 1.13: 95% CI [1.01; 1.25]) were associated with adequate technique for the adjuvant radiotherapy. Laparoscopic surgery increased after 2010 (OR = 1.18: 95% CI [1,10; 1,25]).

      Conclusion

      Improvements should be made to increase the rate of laparoscopy and reduce the delay before adjuvant treatment for the management of endometrial cancer in France, specifically in non-university centers.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Hüsing A.
        • Dossus L.
        • Ferrari P.
        • Tjønneland A.
        • Hansen L.
        • Fagherazzi G.
        • et al.
        An epidemiological model for prediction of endometrial cancer risk in Europe.
        Eur J Epidemiol. 2016; 31 (janv): 51-60
        • Kwon J.S.
        • Carey M.S.
        • Cook E.F.
        • Qiu F.
        • Paszat L.
        Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study.
        Int J Gynecol Cancer. 2007; 17: 433-440
        • Lee C.M.
        • Slomovitz B.M.
        • Greer M.
        • Sharma S.
        • Gregurich M.A.
        • Burke T.
        • et al.
        Practice patterns of SGO members for stage IIIA endometrial cancer.
        Gynecol Oncol. 2005; 98 (juill): 77-83
        • Wright J.D.
        • Hershman D.L.
        • Burke W.M.
        • Lu Y.-S.
        • Neugut A.I.
        • Lewin S.N.
        • et al.
        Influence of surgical volume on outcome for laparoscopic hysterectomy for endometrial cancer.
        Ann Surg Oncol. 2012; 19 (mars): 948-958
        • Becker J.H.
        • Ezendam N.P.M.
        • Boll D.
        • van der Aa M.
        • Pijnenborg J.M.A.
        Effects of surgical volumes on the survival of endometrial carcinoma.
        Gynecol Oncol. 2015; 139 (nov): 306-311
        • Chan J.K.
        • Sherman A.E.
        • Kapp D.S.
        • Zhang R.
        • Osann K.E.
        • Maxwell L.
        • et al.
        Influence of gynecologic oncologists on the survival of patients with endometrial cancer.
        J Clin Oncol. 2011; 29 (1 mars): 832-838
        • Werbrouck J.
        • Bouche G.
        • de Jonge E.
        • Jacomen G.
        • D’Hondt V.
        • et al.
        Evaluation of the quality of the management of cancer of the corpus uteri–selection of relevant quality indicators and implementation in Belgium.
        Gynecol Oncol. 2013; 131 (déc): 512-519
        • Chenoz L.
        • Phelippeau J.
        • Barranger E.
        • Bourdel N.
        • Brun J.L.
        • Chereau E.
        • et al.
        Evaluation and selection of quality indicators for the management of endometrial Cancer.
        Int J Gynecol Cancer. 2017; 27 (juin): 979-986
        • Cohn D.E.
        • Leitao M.
        • Levenback C.
        • Berkowitz R.
        • Roman L.
        • Lucci J.
        • et al.
        Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-exempt Cancer hospitals: an early glimpse into a challenging initiative.
        Gynecol Oncol. 2013; 130 (sept): 403-406
        • Aristizabal P.
        • Graesslin O.
        • Barranger E.
        • Clavel-Chapelon F.
        • Haddad B.
        • Luton D.
        • et al.
        A suggested modification to FIGO stage I endometrial cancer.
        Gynecol Oncol. 2014; 133 (mai): 192-196
        • Poupon C.
        • Bendifallah S.
        • Ouldamer L.
        • Canlorbe G.
        • Raimond E.
        • Hudry N.
        • et al.
        Management and survival of elderly and very elderly patients with endometrial cancer: an age-stratified study of 1228 women from the FRANCOGYN group.
        Ann Surg Oncol. 2017; 24 (juin): 1667-1676
        • Cattaneo R.
        • Hanna R.K.
        • Jacobsen G.
        • Elshaikh M.A.
        Interval between hysterectomy and start of radiation treatment is predictive of recurrence in patients with endometrial carcinoma.
        Int J Radiat Oncol Biol Phys. 2014; 88 (15 mars): 866-871
        • Fabrini M.G.
        • Gadducci A.
        • Perrone F.
        • La Liscia C.
        • Cosio S.
        • et al.
        Relationship between interval from surgery to radiotherapy and local recurrence rate in patients with endometrioid-type endometrial cancer: a retrospective mono-institutional Italian study.
        Anticancer Res. 2012; 32 (janv): 169-173
        • Ahmad N.R.
        • Lanciano R.M.
        • Corn B.W.
        • Schultheiss T.
        Postoperative radiation therapy for surgically staged endometrial cancer: impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome.
        Int J Radiat Oncol Biol Phys. 1995; 33 (1 nov): 837-842
        • Querleu D.
        • Darai E.
        • Lecuru F.
        • Rafii A.
        • Chereau E.
        • Collinet P.
        • et al.
        Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF).
        Gynecol Obstet Fertil Senol. 2017; 45 (déc): 715-725
        • Barillot I.
        • Tavernier E.
        • Peignaux K.
        • Williaume D.
        • Nickers P.
        • et al.
        Impact of post-operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicentre trial.
        Radiother Oncol J Eur Soc Ther Radiol Oncol. 2014; 111 (avr): 138-143
        • Macchia G.
        • Cilla S.
        • Deodato F.
        • Ianiro A.
        • Legge F.
        • Marucci M.
        • et al.
        Simultaneous integrated boost volumetric modulated arc therapy in the postoperative treatment of high-risk to intermediate-risk endometrial cancer: results of ADA II phase 1-2 trial.
        Int J Radiat Oncol Biol Phys. 2016; 96 (01): 606-613
        • Brémond A.
        • Bataillard A.
        • Thomas L.
        • Achard J.-L.
        • Fervers B.
        • Fondrinier E.
        • et al.
        Standards, Options and Recommendations 2000: non metastatic endometrial cancer.
        Bull Cancer (Paris). 2002; 89 (août): 697-706
        • Colombo N.
        • Preti E.
        • Landoni F.
        • Carinelli S.
        • Colombo A.
        • Marini C.
        • et al.
        Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2011; 22 (sept): vi35-39
        • American College of Obstetricians and Gynecologists
        ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 149, April 2015: endometrial cancer.
        Obstet Gynecol. 2015; 125 (Apr): 1006-1026
        • He H.
        • Zeng D.
        • Ou H.
        • Tang Y.
        • Li J.
        • Zhong H.
        Laparoscopic treatment of endometrial cancer: systematic review.
        J Minim Invasive Gynecol. 2013; 20 (août): 413-423
        • Koskas M.
        • Jozwiak M.
        • Fournier M.
        • Vergote I.
        • Trum H.
        • Lok C.
        • et al.
        Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.
        Eur J Cancer. 1990; 2016: 185-191
        • Uccella S.
        • Bonzini M.
        • Palomba S.
        • Fanfani F.
        • Ceccaroni M.
        • Seracchioli R.
        • et al.
        Impact of obesity on surgical treatment for endometrial cancer: a multicenter study comparing laparoscopy vs open surgery, with propensity-matched analysis.
        J Minim Invasive Gynecol. 2016; 23 (janv): 53-61
        • Van den Bosch A.
        • Mertens H.
        Implementation of laparoscopic surgery for endometrial cancer: work in progress.
        Facts Views Vis Obgyn. 2016; 8 (28 mars): 23-30
        • Bergstrom J.
        • Aloisi A.
        • Armbruster S.
        • Yen T.-T.
        • Casarin J.
        • Leitao M.M.
        • et al.
        Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer network (NCCN) Centers.
        Gynecol Oncol. 2018; 148 (mars): 480-484
        • Mannschreck D.
        • Matsuno R.K.
        • Moriarty J.P.
        • Borah B.J.
        • Dowdy S.C.
        • Tanner E.J.
        • et al.
        Disparities in surgical care among women with endometrial cancer.
        Obstet Gynecol. 2016; 128: 526-534
        • Fader A.N.
        • Weise R.M.
        • Sinno A.K.
        • Tanner E.J.
        • Borah B.J.
        • Moriarty J.P.
        • et al.
        Utilization of minimally invasive surgery in endometrial cancer care: a quality and cost disparity.
        Obstet Gynecol. 2016; 127 (janv): 91-100
        • Ran L.
        • Jin J.
        • Xu Y.
        • Bu Y.
        • Song F.
        Comparison of robotic surgery with laparoscopy and laparotomy for treatment of endometrial cancer: a meta- analysis.
        PLoS One. 2014; 9 (sept)e108361
        • Jorgensen S.L.
        • Mogensen O.
        • Wu C.S.
        • Korsholm M.
        • Lund K.
        • Jensen P.T.
        Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study.
        Eur J Cancer. 2019; (jan 2019 – 109)